Tocofer may be available in the countries listed below.
Tocopherol, α- acetate (a derivative of Tocopherol, α-) is reported as an ingredient of Tocofer in the following countries:
International Drug Name Search
Izadima may be available in the countries listed below.
Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Izadima in the following countries:
International Drug Name Search
Céfalexine may be available in the countries listed below.
Céfalexine (DCF) is also known as Cefalexin (Prop.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Prop.INN | Proposed International Nonproprietary Name (World Health Organization) |
Resflor may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Florfenicol is reported as an ingredient of Resflor in the following countries:
Flunixin meglumine (a derivative of Flunixin) is reported as an ingredient of Resflor in the following countries:
International Drug Name Search
Chlorvescent may be available in the countries listed below.
Potassium is reported as an ingredient of Chlorvescent in the following countries:
International Drug Name Search
Ribavirine Teva may be available in the countries listed below.
Ribavirin is reported as an ingredient of Ribavirine Teva in the following countries:
International Drug Name Search
Stericlon may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Stericlon in the following countries:
International Drug Name Search
Channel may be available in the countries listed below.
Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Channel in the following countries:
International Drug Name Search
Forosa may be available in the countries listed below.
Alendronic Acid is reported as an ingredient of Forosa in the following countries:
Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Forosa in the following countries:
International Drug Name Search
Rosiglitazona Richet may be available in the countries listed below.
Rosiglitazone maleate (a derivative of Rosiglitazone) is reported as an ingredient of Rosiglitazona Richet in the following countries:
International Drug Name Search
Masticuran may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Trimethoprim is reported as an ingredient of Masticuran in the following countries:
International Drug Name Search
Gemfibrozilo Fermon may be available in the countries listed below.
Gemfibrozil is reported as an ingredient of Gemfibrozilo Fermon in the following countries:
International Drug Name Search
Xipamid-ratiopharm may be available in the countries listed below.
Xipamide is reported as an ingredient of Xipamid-ratiopharm in the following countries:
International Drug Name Search
Princimox may be available in the countries listed below.
Amoxicillin is reported as an ingredient of Princimox in the following countries:
International Drug Name Search
Oxalisin may be available in the countries listed below.
Oxaliplatin is reported as an ingredient of Oxalisin in the following countries:
International Drug Name Search
Alplax may be available in the countries listed below.
Alprazolam is reported as an ingredient of Alplax in the following countries:
International Drug Name Search
Histodil may be available in the countries listed below.
Cimetidine is reported as an ingredient of Histodil in the following countries:
International Drug Name Search
Lebersdan may be available in the countries listed below.
Protoporphyrin Disodium is reported as an ingredient of Lebersdan in the following countries:
International Drug Name Search
Generic Name: ranitidine bismuth citrate (ra NYE te deen bizz MUTH SI trate)
Brand Names: Tritec
Ranitidine bismuth citrate was withdrawn from the U.S. market in 1998.
Ranitidine is in a class of drugs called histamine receptor antagonists. Ranitidine works by decreasing the amount of acid your stomach produces.
Bismuth is a mild antibiotic.
Citrate is a form of salt.
Ranitidine bismuth citrate is used to decrease the amount of acid in the stomach and to treat Helicobacter pylori, a bacterial infection involved in causing stomach ulcers. Ranitidine bismuth citrate is most commonly used with clarithromycin (Biaxin), an antibiotic, to treat this infection.
Ranitidine bismuth citrate may also be used for conditions other than those listed in this medication guide.
Ranitidine bismuth citrate was withdrawn from the U.S. market in 1998.
Before taking this medication, tell your doctor if you have
liver disease; or
acute porphyria.
You may not be able to take ranitidine bismuth citrate, or you may require a lower dose or special monitoring during treatment if you have any of the conditions listed above.
Take ranitidine bismuth citrate exactly as directed by your doctor. If you do not understand these instructions, ask your pharmacist, nurse, or doctor to explain them to you.
Ranitidine bismuth citrate is usually taken twice a day (every 12 hours) for 4 weeks. You will probably also take the antibiotic clarithromycin (Biaxin) three times a day for the first 2 weeks of therapy. Follow your doctor's instructions.
See also: Ranitidine bismuth citrate dosage (in more detail)
Take the missed dose as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take only your next regularly scheduled dose. Do not take a double dose of this medication unless otherwise directed by your doctor.
Symptoms of a ranitidine bismuth citrate overdose are not known but might include nausea, vomiting, diarrhea, increased saliva production, shaking, difficulty breathing, and a fast heartbeat.
There are no restrictions on food, beverages, or activity while taking ranitidine bismuth citrate unless your doctor directs otherwise.
Other, less serious side effects may be more likely to occur. Continue to take ranitidine bismuth citrate and talk to your doctor if you experience
changes in taste;
headache or dizziness;
diarrhea, nausea, or constipation; or
tremor (shaking).
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.
Usual Adult Dose for Duodenal Ulcer:
Ranitidine bismuth citrate was voluntarily withdrawn from the US market by the manufacturer in 1998. The following dosage information applies to when the drug was available in the U.S. Also, treatment guidelines issued by the American College of Gastroenterology no longer include dual-therapy.
Associated with H. Pylori: 400 mg orally twice a day for 28 days.
Before taking ranitidine bismuth citrate, tell your doctor if you are taking any of the following medicines:
Sedatives, sleeping pills, or tranquilizers such as alprazolam (Xanax), diazepam (Valium), and chlordiazepoxide (Librium) may cause dangerous sedation when taken with ranitidine bismuth citrate.
Anticoagulants (blood thinners) such as warfarin (Coumadin) may have increased effects, which could result in bleeding.
Seizure medications such as phenytoin (Dilantin) and carbamazepine (Tegretol) may have dangerous side effects when taken with ranitidine bismuth citrate.
Medications for heart disorders, such as procainamide (Procanbid, Procan SR, Pronestyl), propranolol (Inderal), and metoprolol (Lopressor), may have increased effects on your heart when you are taking ranitidine bismuth citrate.
Oral diabetes drugs such as glipizide (Glucotrol), glyburide (Diabeta, Micronase), and tolbutamide (Tolinase) may have increased effects, and very low blood sugar levels may result.
Cisapride (Propulsid), which is taken for stomach conditions, as well as antifungal drugs such as ketoconazole (Nizoral), itraconazole (Sporanox), and fluconazole (Diflucan), may increase side effects.
Drugs other than those listed here may also interact with ranitidine bismuth citrate. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.
Ranitidine bismuth citrate was withdrawn from the U.S. market in 1998.
See also: ranitidine bismuth citrate side effects (in more detail)
Eye Rinderon may be available in the countries listed below.
Betamethasone 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Eye Rinderon in the following countries:
International Drug Name Search
Kuradoid may be available in the countries listed below.
Sodium Alginate Sulfate is reported as an ingredient of Kuradoid in the following countries:
International Drug Name Search
Kamfolin may be available in the countries listed below.
Methyl Salicylate is reported as an ingredient of Kamfolin in the following countries:
International Drug Name Search
Riboposid may be available in the countries listed below.
Etoposide is reported as an ingredient of Riboposid in the following countries:
International Drug Name Search
Klabax may be available in the countries listed below.
Clarithromycin is reported as an ingredient of Klabax in the following countries:
International Drug Name Search
Apo-Nicotinic acid may be available in the countries listed below.
Nicotinic Acid is reported as an ingredient of Apo-Nicotinic acid in the following countries:
International Drug Name Search
Klismacort may be available in the countries listed below.
Prednisolone is reported as an ingredient of Klismacort in the following countries:
International Drug Name Search
Antidepressa may be available in the countries listed below.
Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Antidepressa in the following countries:
International Drug Name Search
Camelox may be available in the countries listed below.
Meloxicam is reported as an ingredient of Camelox in the following countries:
International Drug Name Search
Rec.INN
S01AX05
0006915-57-7
C6-H-Bi-Br4-O3
649
Antiseptic
Disinfectant
1,3,2-Benzodioxabismole, 4,5,6,7-tetrabromo-2-hydroxy-
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Elosalic may be available in the countries listed below.
Mometasone 17-(2-furoate) (a derivative of Mometasone) is reported as an ingredient of Elosalic in the following countries:
Salicylic Acid is reported as an ingredient of Elosalic in the following countries:
International Drug Name Search
Localyn may be available in the countries listed below.
Fluocinolone Acetonide is reported as an ingredient of Localyn in the following countries:
International Drug Name Search
Miconazol / Hydrocortison PCH may be available in the countries listed below.
Hydrocortisone is reported as an ingredient of Miconazol / Hydrocortison PCH in the following countries:
Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Miconazol / Hydrocortison PCH in the following countries:
International Drug Name Search
Decamin may be available in the countries listed below.
Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Decamin in the following countries:
International Drug Name Search
Minesse may be available in the countries listed below.
Ethinylestradiol is reported as an ingredient of Minesse in the following countries:
Gestodene is reported as an ingredient of Minesse in the following countries:
International Drug Name Search
Azitromicina Northia may be available in the countries listed below.
Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Azitromicina Northia in the following countries:
International Drug Name Search
Kaosyl may be available in the countries listed below.
Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Kaosyl in the following countries:
International Drug Name Search
Orsinon may be available in the countries listed below.
Tolbutamide is reported as an ingredient of Orsinon in the following countries:
International Drug Name Search
Tebesium DUO may be available in the countries listed below.
Isoniazid is reported as an ingredient of Tebesium DUO in the following countries:
Rifampicin is reported as an ingredient of Tebesium DUO in the following countries:
International Drug Name Search
Eritromed may be available in the countries listed below.
Erythromycin estolate (a derivative of Erythromycin) is reported as an ingredient of Eritromed in the following countries:
Erythromycin lactobionate (a derivative of Erythromycin) is reported as an ingredient of Eritromed in the following countries:
International Drug Name Search
Clomipramine HCl ratiopharm may be available in the countries listed below.
Clomipramine hydrochloride (a derivative of Clomipramine) is reported as an ingredient of Clomipramine HCl ratiopharm in the following countries:
International Drug Name Search
Glukolos may be available in the countries listed below.
Gliclazide is reported as an ingredient of Glukolos in the following countries:
International Drug Name Search
Orfadin is a brand name of nitisinone, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Orfadin available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Orfadin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Dopamina Galenica may be available in the countries listed below.
Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of Dopamina Galenica in the following countries:
International Drug Name Search
Ciclosporin-1A Pharma may be available in the countries listed below.
Ciclosporin is reported as an ingredient of Ciclosporin-1A Pharma in the following countries:
International Drug Name Search
Ciprofloxacin TAD may be available in the countries listed below.
Ciprofloxacin is reported as an ingredient of Ciprofloxacin TAD in the following countries:
Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprofloxacin TAD in the following countries:
International Drug Name Search
DTIC-Dome can cause severe, even fatal, liver problems (hepatic necroses), or a decrease in the formation of new blood cells (hemopoietic depression). It has also caused cancer and birth defects in laboratory animals. Notify your doctor immediately if you develop symptoms of an infection (eg, persistent sore throat or fever), easy bruising or bleeding, nausea, dark urine, unusual fatigue, yellowing of the eyes or skin, or stomach pain. Your doctor will monitor you closely while you are using DTIC-Dome.
Treating certain cancers (eg, advanced skin cancer) and Hodgkin disease. It may be used with other medicines. It may also be used for other conditions as determined by your doctor.
DTIC-Dome is an antineoplastic agent. It is not known exactly how DTIC-Dome works. It may block the growth of cancer cells.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with DTIC-Dome. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with DTIC-Dome. However, no specific interactions with DTIC-Dome are known at this time.
This may not be a complete list of all interactions that may occur. Ask your health care provider if DTIC-Dome may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use DTIC-Dome as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use DTIC-Dome.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Facial flushing, numbness, or tingling; loss of appetite; metallic taste in mouth; muscle pain or weakness; nausea; temporary hair loss; vomiting.
Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); dark urine; fever, chills, or sore throat; joint pain; pain, redness, or swelling at injection site; severe nausea and vomiting; stomach pain; unusual bruising or bleeding; unusual tiredness or weakness; yellowing of skin or eyes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: DTIC-Dome side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (http://www.aapcc.org ), or emergency room immediately.
DTIC-Dome is usually handled and stored by a health care provider. If you are using DTIC-Dome at home, store DTIC-Dome as directed by your pharmacist or health care provider. Keep DTIC-Dome, as well as needles and syringes, out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about DTIC-Dome. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Alfaprostololo may be available in the countries listed below.
Alfaprostololo (DCIT) is also known as Alfaprostol (Rec.INN)
International Drug Name Search
Glossary
| DCIT | Denominazione Comune Italiana |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Aerius Kids may be available in the countries listed below.
Desloratadine is reported as an ingredient of Aerius Kids in the following countries:
International Drug Name Search
Klarixol may be available in the countries listed below.
Clarithromycin is reported as an ingredient of Klarixol in the following countries:
International Drug Name Search
Hisrack may be available in the countries listed below.
Etodolac is reported as an ingredient of Hisrack in the following countries:
International Drug Name Search
Drossafol may be available in the countries listed below.
Folic Acid is reported as an ingredient of Drossafol in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Prednisolone 21-(sodium succinate) (a derivative of Prednisolone) is reported as an ingredient of Solu Delta Cortef in the following countries:
International Drug Name Search
Augmentine Plus may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Augmentine Plus in the following countries:
Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Augmentine Plus in the following countries:
International Drug Name Search
Capros may be available in the countries listed below.
Morphine sulphate pentahydrate (a derivative of Morphine) is reported as an ingredient of Capros in the following countries:
International Drug Name Search
Hobaticam may be available in the countries listed below.
Tenoxicam is reported as an ingredient of Hobaticam in the following countries:
International Drug Name Search
Vitamin A Acid may be available in the countries listed below.
Tretinoin is reported as an ingredient of Vitamin A Acid in the following countries:
International Drug Name Search
Dosan may be available in the countries listed below.
Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Dosan in the following countries:
International Drug Name Search
Dexa-M may be available in the countries listed below.
Dexamethasone is reported as an ingredient of Dexa-M in the following countries:
Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Dexa-M in the following countries:
International Drug Name Search
Miodom may be available in the countries listed below.
Tolperisone hydrochloride (a derivative of Tolperisone) is reported as an ingredient of Miodom in the following countries:
International Drug Name Search
Lafayette Rifampicin may be available in the countries listed below.
Rifampicin is reported as an ingredient of Lafayette Rifampicin in the following countries:
International Drug Name Search
Klaxon may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Klaxon in the following countries:
International Drug Name Search
Simeticona Cetus may be available in the countries listed below.
Simeticone is reported as an ingredient of Simeticona Cetus in the following countries:
International Drug Name Search
Fensartan may be available in the countries listed below.
Losartan is reported as an ingredient of Fensartan in the following countries:
International Drug Name Search
PMS-Simvastatin may be available in the countries listed below.
Simvastatin is reported as an ingredient of PMS-Simvastatin in the following countries:
International Drug Name Search
Apo-Orciprenaline may be available in the countries listed below.
Orciprenaline sulfate (a derivative of Orciprenaline) is reported as an ingredient of Apo-Orciprenaline in the following countries:
International Drug Name Search
droe-SPYE-re-none, ETH-i-nil es-tra-DYE-ol
Cigarette smoking increases the risk of serious cardiovascular events from oral contraceptive use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. Women who are over 35 years of age and smoke should not use oral contraceptives .
In the U.S.
Available Dosage Forms:
Therapeutic Class: Monophasic Contraceptive Combination
Pharmacologic Class: Progestin
Drospirenone and ethinyl estradiol combination is used as an oral contraceptive. Oral contraceptives are known also as the Pill, OCs, BCs, BC tablets, or birth control pills. drospirenone and ethinyl estradiol usually contains two types of hormones, estrogens and progestins and, when taken properly, prevents pregnancy. It works by stopping a woman's egg from fully developing each month. The egg can no longer accept a sperm and fertilization is prevented. Although oral contraceptives have other effects that help prevent a pregnancy from occurring, this is the main action.
drospirenone and ethinyl estradiol is also used to treat premenstrual dysphoric disorder (PMDD). PMDD is a severe form of premenstrual syndrome (PMS). Patients with PMDD may experience severe emotional and physical symptoms 10 to 14 days before their menstrual flow starts .
No contraceptive method is 100 percent effective. Discuss with your health care professional your options for birth control .
Drospirenone and ethinyl estradiol combination is also used to treat acne in women at least 14 years of age, who have already started menstruating and choose to use a birth control pill to prevent pregnancy .
drospirenone and ethinyl estradiol is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For drospirenone and ethinyl estradiol, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to drospirenone and ethinyl estradiol or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
drospirenone and ethinyl estradiol is not intended for use in children or teenagers who have not yet started menstruating. drospirenone and ethinyl estradiol is frequently used for birth control in teenage females and has not been shown to cause different side effects or problems than it does in adults. Some teenagers may need extra information on the importance of taking this medication exactly as prescribed.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | X | Studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. This drug should not be used in women who are or may become pregnant because the risk clearly outweighs any possible benefit. |
Studies in women breastfeeding have demonstrated harmful infant effects. An alternative to this medication should be prescribed or you should stop breastfeeding while using drospirenone and ethinyl estradiol.
Studies suggest that this medication may alter milk production or composition. If an alternative to this medication is not prescribed, you should monitor the infant for side effects and adequate milk intake.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking drospirenone and ethinyl estradiol, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using drospirenone and ethinyl estradiol with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using drospirenone and ethinyl estradiol with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using drospirenone and ethinyl estradiol with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using drospirenone and ethinyl estradiol with any of the following may cause an increased risk of certain side effects but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use drospirenone and ethinyl estradiol, or give you special instructions about the use of food, alcohol, or tobacco.
The presence of other medical problems may affect the use of drospirenone and ethinyl estradiol. Make sure you tell your doctor if you have any other medical problems, especially:
Make certain your health care professional knows if you are on any special diet, such as a low-sodium or low-sugar diet.
To make using oral contraceptives as safe and reliable as possible, you should understand how and when to take them and what effects may be expected.
A paper with information for the patient will be given to you with your filled prescription, and will provide many details concerning the use of oral contraceptives. Read this paper carefully and ask your health care professional if you need additional information or explanation.
When you begin to use oral contraceptives, your body will require at least 7 days to adjust before a pregnancy will be prevented. You will need to use an additional birth control method for at least 7 days. Some doctors recommend using an additional method of birth control for the first cycle (or 3 weeks) to ensure full protection. Follow the advice of your doctor or other health care professional.
Try to take the doses no more than 24 hours apart to reduce the possibility of side effects and to prevent pregnancy. Since one of the most important factors in the proper use of oral contraceptives is taking every dose exactly on schedule, you should never let your tablet supply run out. When possible, try to keep an extra month's supply of tablets on hand and replace it monthly.
It is very important that you keep the tablets in their original container and take the tablets in the same order that they appear in the container. The containers help you keep track of which tablets to take next. Different colored tablets in the same package contain different amounts of hormones or are placebos (tablets that do not contain hormones). The effectiveness of the medicine is reduced if the tablets are taken out of order.
The dose of drospirenone and ethinyl estradiol will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of drospirenone and ethinyl estradiol. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
Your doctor may ask you to begin your dose on the first day of your menstrual period (called Day 1 start) or on Sunday after your period starts (called Sunday start). When you begin on a certain day it is important that you follow that schedule, even when you miss a dose. Do not change your schedule on your own. If the schedule that you have been put on is not convenient, check with your doctor about changing schedules. For Sunday start you need to use another form of birth control for the first 7 days.
For Yasmin(R) and Yaz(R), begin next and all subsequent 28-day regimens of therapy on the same day of the week as the first regimen began and follow the same schedule .
Call your doctor or pharmacist for instructions.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Ask your healthcare professional how you should dispose of any medicine you do not use.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
It is very important that your doctor check your progress at regular visits to make sure drospirenone and ethinyl estradiol does not cause unwanted effects. These visits will usually be every 6 to 12 months, but some doctors require them more often.
drospirenone and ethinyl estradiol will not protect you from getting HIV/AIDS or other sexually transmitted diseases. If this is a concern for you, talk with your doctor .
Tell the medical doctor or dentist in charge that you are taking drospirenone and ethinyl estradiol before any kind of surgery (including dental surgery) or emergency treatment. Your doctor will decide whether you should continue taking drospirenone and ethinyl estradiol .
Vaginal bleeding of various amounts may occur between your regular menstrual periods during the first 3 months of use. This is sometimes called spotting when slight, or breakthrough bleeding when heavier. If this should occur:
Missed menstrual periods may occur:
Check with your doctor if you miss any menstrual periods so that the cause may be determined.
If you suspect that you may have become pregnant, stop taking drospirenone and ethinyl estradiol immediately and check with your doctor.
If you are scheduled for any laboratory tests, tell your doctor that you are taking birth control pills.
Check with your doctor before refilling an old prescription, especially after a pregnancy. You will need another physical examination and your doctor may change your prescription.
Check with your doctor immediately if you wear contact lenses or if blurred vision, difficulty in reading, or any other change in vision occurs during or after treatment. Your doctor may want you to have your eyes checked by an ophthalmologist (eye doctor) .
Healthy women who do not smoke cigarettes have almost no chance of having a severe side effect from taking oral contraceptives. For most women, more problems occur because of pregnancy than will occur from taking oral contraceptives. But for some women who have special health problems, oral contraceptives can cause some unwanted effects. Some of these unwanted effects include benign (not cancerous) liver tumors, liver cancer, or blood clots or related problems, such as a stroke. Although these effects are very rare, they can be serious enough to cause death. You may want to discuss these effects with your doctor.
Smoking cigarettes during the use of oral contraceptives has been found to greatly increase the chances of these serious side effects occurring. To reduce the risk of serious side effects, do not smoke cigarettes while you are taking oral contraceptives.
Check with your doctor immediately if any of the following side effects occur:
Check with your doctor as soon as possible if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: drospirenone and ethinyl estradiol side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Moclobemid Hexal may be available in the countries listed below.
Moclobemide is reported as an ingredient of Moclobemid Hexal in the following countries:
International Drug Name Search
Korispar may be available in the countries listed below.
Chlorphenesin Carbamate is reported as an ingredient of Korispar in the following countries:
International Drug Name Search
Milamet may be available in the countries listed below.
Cimetidine is reported as an ingredient of Milamet in the following countries:
International Drug Name Search
Kanamytrex may be available in the countries listed below.
Kanamycin sulfate (a derivative of Kanamycin) is reported as an ingredient of Kanamytrex in the following countries:
International Drug Name Search
CSI-S may be available in the countries listed below.
Ceftriaxone is reported as an ingredient of CSI-S in the following countries:
Sulbactam is reported as an ingredient of CSI-S in the following countries:
International Drug Name Search
Protect may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Permethrin is reported as an ingredient of Protect in the following countries:
Pyriproxyfen is reported as an ingredient of Protect in the following countries:
International Drug Name Search
Kokain SAD may be available in the countries listed below.
Cocaine hydrochloride (a derivative of Cocaine) is reported as an ingredient of Kokain SAD in the following countries:
International Drug Name Search
Risperatio may be available in the countries listed below.
Risperidone is reported as an ingredient of Risperatio in the following countries:
International Drug Name Search
Noripurum may be available in the countries listed below.
Iron Polymaltose is reported as an ingredient of Noripurum in the following countries:
International Drug Name Search
Berinin may be available in the countries listed below.
Coagulation Factor IX, Human is reported as an ingredient of Berinin in the following countries:
International Drug Name Search
Sandoz Anagrelide may be available in the countries listed below.
Anagrelide hydrochloride (a derivative of Anagrelide) is reported as an ingredient of Sandoz Anagrelide in the following countries:
International Drug Name Search
Oxycod Syrup may be available in the countries listed below.
Oxycodone hydrochloride (a derivative of Oxycodone) is reported as an ingredient of Oxycod Syrup in the following countries:
International Drug Name Search
Histatec may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Histatec in the following countries:
International Drug Name Search
Econazole Arrow may be available in the countries listed below.
Econazole nitrate (a derivative of Econazole) is reported as an ingredient of Econazole Arrow in the following countries:
International Drug Name Search
Kortikoid-ratiopharm may be available in the countries listed below.
Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Kortikoid-ratiopharm in the following countries:
International Drug Name Search
Caleobrol may be available in the countries listed below.
Calcitriol is reported as an ingredient of Caleobrol in the following countries:
International Drug Name Search
Mercryl may be available in the countries listed below.
Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Mercryl in the following countries:
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Mercryl in the following countries:
International Drug Name Search
